EMBECTA CORP. Dividends, Common Stock
EMBECTA CORP. (EMBC) reported Dividends, Common Stock of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCommonStock · last filed 2026-08-07
- EMBECTA CORP. dividends, common stock for the quarter ending 2026-06-30 was $600.00K, a 93.10% decline year-over-year.
- EMBECTA CORP. dividends, common stock for the quarter ending 2026-03-31 was $8.90M, a 2.30% increase year-over-year.
- EMBECTA CORP. dividends, common stock for the quarter ending 2025-12-31 was $8.90M, a 1.14% increase year-over-year.
- EMBECTA CORP. dividends, common stock for the quarter ending 2025-09-30 was $8.80M, a 1.15% increase year-over-year.
- EMBECTA CORP. dividends, common stock for fiscal 2025 was $35.00M, a 1.45% increase from fiscal 2024.
- EMBECTA CORP. dividends, common stock for fiscal 2024 was $34.50M, a 0.29% increase from fiscal 2023.
- EMBECTA CORP. dividends, common stock for fiscal 2023 was $34.40M, a 300.00% increase from fiscal 2022.
- EMBECTA CORP. dividends, common stock for fiscal 2022 was $8.60M.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-07 | $9.50M derived: sum of 2 quarters · filed 2026-08-07 | $18.40M 10-Q · filed 2026-08-07 | $27.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $8.90M 10-Q · filed 2026-05-05 | $17.80M 10-Q · filed 2026-05-05 | $26.60M derived: sum of 3 quarters · filed 2026-05-05 | $35.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $8.90M 10-Q · filed 2026-02-05 | $17.70M derived: sum of 2 quarters · filed 2026-02-05 | $26.40M derived: sum of 3 quarters · filed 2026-08-07 | $35.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $17.50M derived: sum of 2 quarters · filed 2026-08-07 | $26.20M derived: sum of 3 quarters · filed 2026-08-07 | $35.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $8.70M 10-Q · filed 2026-08-07 | $17.40M derived: sum of 2 quarters · filed 2026-08-07 | $26.20M 10-Q · filed 2026-08-07 | $34.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $8.70M 10-Q · filed 2026-05-05 | $17.50M 10-Q · filed 2026-05-05 | $26.20M derived: sum of 3 quarters · filed 2026-05-05 | $34.80M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $8.80M 10-Q · filed 2026-02-05 | $17.50M derived: sum of 2 quarters · filed 2026-02-05 | $26.10M derived: sum of 3 quarters · filed 2026-02-05 | $34.70M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $17.30M derived: sum of 2 quarters · filed 2025-11-25 | $25.90M derived: sum of 3 quarters · filed 2025-11-25 | $34.50M 10-K · filed 2025-11-25 |
| 2024-06-30 | $8.60M 10-Q · filed 2025-08-08 | $17.20M derived: sum of 2 quarters · filed 2025-08-08 | $25.80M 10-Q · filed 2025-08-08 | $34.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $8.60M 10-Q · filed 2025-05-09 | $17.20M 10-Q · filed 2025-05-09 | $25.80M derived: sum of 3 quarters · filed 2025-11-25 | $34.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $8.60M 10-Q · filed 2025-02-06 | $17.20M derived: sum of 2 quarters · filed 2025-11-25 | $25.80M derived: sum of 3 quarters · filed 2025-11-25 | $34.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $17.20M derived: sum of 2 quarters · filed 2025-11-25 | $25.80M derived: sum of 3 quarters · filed 2025-11-25 | $34.40M 10-K · filed 2025-11-25 |
| 2023-06-30 | $8.60M 10-Q · filed 2024-08-09 | $17.20M derived: sum of 2 quarters · filed 2024-08-09 | $25.80M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $8.60M 10-Q · filed 2024-05-09 | $17.20M 10-Q · filed 2024-05-09 | ||
| 2022-12-31 | $8.60M 10-Q · filed 2024-02-09 | |||
| 2022-09-30 | $8.60M 10-K · filed 2024-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |